Growatt is pre-marketing a US$1.0 billion HKEx IPO. In this note, we present our forecasts and take the first look at Giant Biogene's potential valuation range.
Equity Capital Markets
365 Views, 27 Nov 2022 22:44
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network